New weapon against advanced cancer enters human testing
Disease control
Recruiting now
This is the first study in people testing a new cancer drug called AGX101. It aims to find a safe and effective dose for patients with advanced solid tumors that have spread or cannot be removed by surgery, and who have no other standard treatment options left. The drug is given …
Phase: PHASE1 • Sponsor: Angiex, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC